Amneal Pharmaceuticals (AMRX)
Developer and manufacturer of generics, injectables, biosimilars, and branded neurology medicines.
$19.00
vs last close−0.50 (−2.57%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 36 days
EPS estimate
$0.23
Revenue estimate
$812.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Jul '26Oct '26
Reported$0.12$0.21$0.25$0.17$0.21$0.27$0.30Pending
Estimate$0.15$0.15$0.18$0.13$0.18$0.17$0.22$0.23
Surprise−20.0%+40.0%+38.9%+30.8%+16.7%+58.8%+34.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Oct '25Feb '26May '26Jul '26Oct '26
Reported$730.5M$695.4M$724.5M$784.5M$814.3M$722.5M$796.2MPending
Estimate$723.1M$744.2M$768.6M$806.1M$807.4M$719.7M$768.2M$812.9M
Surprise+1.0%−6.6%−5.7%−2.7%+0.9%+0.4%+3.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.40 | — | — |
| Sep 2027 | $0.32 | — | — |
| Jun 2027 | $0.30 | — | — |
| Mar 2027 | $0.25 | — | — |
| Dec 2026 | $0.22 | — | — |
| Oct 2026 | $0.23 | — | — |
| Jul 2026 | $0.22 | $0.30 | +34.8% |
| May 2026 | $0.17 | $0.27 | +58.8% |
| Feb 2026 | $0.18 | $0.21 | +16.7% |
| Oct 2025 | $0.13 | $0.17 | +30.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.40 | — | — | $1.01B | — | — | — |
| Sep 2027 | $0.32 | — | — | $858.9M | — | — | — |
| Jun 2027 | $0.30 | — | — | $824.6M | — | — | — |
| Mar 2027 | $0.25 | — | — | $765.2M | — | — | — |
| Dec 2026 | $0.22 | — | — | $822.5M | — | — | — |
| Oct 29, 2026 | $0.23 | — | — | $812.9M | — | — | — |
| Jul 30, 2026 | $0.22 | $0.30 | +34.8% | $768.2M | $796.2M | +3.6% | −3.1% |
| May 7, 2026 | $0.17 | $0.27 | +58.8% | $719.7M | $722.5M | +0.4% | +0.7% |
| Feb 27, 2026 | $0.18 | $0.21 | +16.7% | $807.4M | $814.3M | +0.9% | −4.7% |
| Oct 30, 2025 | $0.13 | $0.17 | +30.8% | $806.1M | $784.5M | −2.7% | −4.1% |
| Aug 5, 2025 | |||||||
| May 2, 2025 | |||||||
| Feb 28, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 3, 2024 | |||||||
| Mar 1, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 4, 2023 | |||||||
| May 5, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Nov 4, 2022 | |||||||
| Aug 5, 2022 | |||||||
| May 4, 2022 | |||||||
| Mar 2, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 7, 2021 | |||||||
| Feb 26, 2021 | |||||||
| Nov 6, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 11, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 5, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 7, 2018 | |||||||
| Mar 1, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Feb 22, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |